Desmycosin is primarily used in the pharmaceutical industry due to its antimicrobial properties. It serves as an intermediate in the synthesis of macrolide antibiotics, which are effective against a range of Gram-positive bacteria and some Gram-negative strains. Its structure allows for chemical modifications that enhance antibiotic activity or reduce bacterial resistance. It has also been explored for use in veterinary medicine, particularly in treating respiratory infections in livestock. Additionally, desmycosin's role in inhibiting protein synthesis in bacterial cells makes it a candidate for developing new anti-infective agents. Research continues into its potential applications in combating multidrug-resistant pathogens.